Schedule 13D Page 1 of 6
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)
THE MEDICINES COMPANY, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.001 Par Value
--------------------------------------------------------------------------------
(Title of Class of Securities)
584688 10 5
--------------------------------------------------------------------------------
(CUSIP Number)
Scott A. Arenare, Esq.
Managing Director and General Counsel
Warburg Pincus LLC
466 Lexington Avenue
New York, New York 10017
(212) 878-0600
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
Copies to:
Peter H. Jakes, Esq.
Willkie Farr & Gallagher
787 Seventh Avenue
New York, New York 10019-6099
(212) 728-8000
December 12, 2002
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss.240.13d-l(e), 240.13d-l(f) or 240.13d-1(g), check the
following box. [ ]
Schedule 13D Page 2 of 6
CUSIP No.584688 10 5
--------------------------------------------------------------------------------
1. Names of Reporting Persons. I.R. S. Nos. of above persons
(entities only).
Warburg, Pincus Ventures, L.P. I.R.S. #13-3784037
------------ ------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) [ ]
(b) [x]
------------ ------------------------------------------------------------------
3. SEC Use Only
------------ ------------------------------------------------------------------
4. Source of Funds (See Instructions)
WC
------------ ------------------------------------------------------------------
5. Check if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e)
------------ ------------------------------------------------------------------
6. Citizenship or Place of Organization
Delaware
------------ ------------------------------------------------------------------
Number of
Shares 7. Sole Voting Power
Beneficially
Owned by 0
Each -----------------------------------------------------------
Reporting
Person 8. Shared Voting Power
With
1,641,601
------------------------------------------------------------------
9. Sole Dispositive Power
0
------------------------------------------------------------------
10. Shared Dispositive Power
1,641,601
------------ ------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
1,641,601
------------ ------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
------------ ------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11) 4.0%
------------ ------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
PN
Schedule 13D Page 3 of 6
CUSIP No.584688 10 5
--------------------------------------------------------------------------------
1. Names of Reporting Persons. I.R. S. Nos. of above persons
(entities only).
Warburg Pincus & Co. I.R.S. #13-6358475
------------ ------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) [ ]
(b) [x]
------------ ------------------------------------------------------------------
3. SEC Use Only
------------ ------------------------------------------------------------------
4. Source of Funds (See Instructions)
WC
------------ ------------------------------------------------------------------
5. Check if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e)
------------ ------------------------------------------------------------------
6. Citizenship or Place of Organization
New York
------------ ------------------------------------------------------------------
Number of
Shares 7. Sole Voting Power
Beneficially
Owned by 0
Each
Reporting -----------------------------------------------------------
Person
With 8. Shared Voting Power
1,641,601
-----------------------------------------------------------
9. Sole Dispositive Power
0
-----------------------------------------------------------
10. Shared Dispositive Power
1,641,601
------------ ------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
1,641,601
------------ ------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
------------ ------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11) 4.0%
------------ ------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
PN
Schedule 13D Page 4 of 6
CUSIP No.584688 10 5
--------------------------------------------------------------------------------
1. Names of Reporting Persons. I.R. S. Nos. of above persons
(entities only).
Warburg Pincus LLC
(formerly E.M. Warburg, Pincus & Co., LLC) I.R.S. #13-3536050
------------ ------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) [ ]
(b) [x]
------------ ------------------------------------------------------------------
3. SEC Use Only
------------ ------------------------------------------------------------------
4. Source of Funds (See Instructions)
WC
------------ ------------------------------------------------------------------
5. Check if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e)
------------ ------------------------------------------------------------------
6. Citizenship or Place of Organization
New York
------------ ------------------------------------------------------------------
Number of
Shares 7. Sole Voting Power
Beneficially
Owned by 0
Each
Reporting -----------------------------------------------------------
Person
With 8. Shared Voting Power
1,641,601
-----------------------------------------------------------
9. Sole Dispositive Power
0
-----------------------------------------------------------
10. Shared Dispositive Power
1,641,601
------------ ------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
1,641,601
------------ ------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
------------ ------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11) 4.0%
------------ ------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
OO
Schedule 13D Page 5 of 6
This Amendment No. 3 amends the Schedule 13D filed on May 23, 2001, as
amended by Amendment No. 1 filed on July 29, 2002 and Amendment No. 2 filed on
November 22, 2002 (as amended the "Schedule 13D") on behalf of Warburg, Pincus
Ventures, L.P., a Delaware limited partnership ("Ventures"), Warburg Pincus &
Co., a New York general partnership ("WP") and Warburg Pincus LLC (formerly E.M.
Warburg, Pincus & Co., LLC), a New York limited liability company ("WP LLC" and,
together with WPV and WP, the "Reporting Entities"). This Schedule 13D relates
to the Common Stock, par value $0.001, of The Medicines Company, Inc., a
corporation organized under Delaware law (the "Company"). Unless the context
otherwise requires, references herein to the "Common Stock" are to the Common
Stock of the Company, par value $0.001 per share.
Unless otherwise indicated herein, each capitalized term used but not
defined herein shall have the meaning assigned to such term in the Schedule 13D.
Item 5. Interest in Securities of the Issuer
Item 5 of the Schedule 13D is hereby amended by adding the following:
On December 12, 2002, Ventures distributed 2,509,657 shares of Common Stock
to its partners. As of such date and after giving effect to the distribution,
the Reporting Persons beneficially owned 1,641,601 shares of Common Stock, or
approximately 4.0% of the shares of Common Stock outstanding (comprised of (i)
39,299,967 shares of Common Stock outstanding as of October 23, 2002; and (ii)
1,275,810 additional shares of Common Stock issuable on the exercise of the
immediately exercisable warrants held by Ventures). On December 12, 2002, the
Reporting Persons ceased to be the beneficial owners of more than 5% of the
Common Stock.
Schedule 13D Page 6 of 6
Signatures
After reasonable inquiry and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.
Dated: December 16, 2002 WARBURG, PINCUS VENTURES,
L.P.
By: Warburg, Pincus & Co.,
General Partner
By: /s/ Scott A. Arenare
--------------------------
Name: Scott A. Arenare
Title: General Partner
Dated: December 16, 2002 WARBURG PINCUS & CO.
By: /s/ Scott A. Arenare
--------------------------
Name: Scott A. Arenare
Title: General Partner
Dated: December 16, 2002 WARBURG PINCUS LLC
By: /s/ Scott A. Arenare
--------------------------
Name: Scott A. Arenare
Title: Managing Director